Published in Rheumatol Int on August 14, 2014
A Possible Role of Intestinal Microbiota in the Pathogenesis of Ankylosing Spondylitis. Int J Mol Sci (2016) 0.76
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut (2012) 12.62
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis (2009) 8.37
Ankylosing spondylitis. Lancet (2007) 6.58
Clinical practice. Helicobacter pylori infection. N Engl J Med (2010) 4.94
Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest (2011) 2.77
Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet (2002) 2.71
ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis (2008) 2.37
Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. BMJ (1988) 2.28
The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol (1995) 1.99
Seroconversion for Helicobacter pylori. Lancet (1993) 1.88
DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. J Clin Invest (2012) 1.68
The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. J Rheumatol (1995) 1.51
High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum (1994) 1.50
Helicobacter pylori infection--a boon or a bane: lessons from studies in a low-prevalence population. Helicobacter (2013) 1.38
Serological antibodies in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis (2011) 1.30
Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol (2010) 1.23
A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland. Arthritis Rheum (2007) 1.22
Incidence of spondyloarthropathy in patients with Crohn's disease: a population-based study. J Rheumatol (2012) 1.06
Seroprevalence of Helicobacter pylori infection in inflammatory bowel disease: is Helicobacter pylori infection a protective factor? Scand J Gastroenterol (2001) 0.95
Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy. Ann Rheum Dis (2003) 0.95
Evidence for significant overlap between common risk variants for Crohn's disease and ankylosing spondylitis. PLoS One (2010) 0.91
Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role. Ann N Y Acad Sci (2009) 0.90
Macroscopic and microscopic gut lesions in seronegative spondyloarthropathies. J Rheumatol (1990) 0.87
Helicobacter pylori and autoimmune diseases. Oral Dis (2011) 0.86
Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthropathies: a reassessment. Rheumatology (Oxford) (2007) 0.82
Role of seroconversion in confirming cure of Helicobacter pylori infection. JAMA (1998) 0.78
Clinically silent inflammatory gut lesions in undifferentiated spondyloarthropathies. Clin Rheumatol (1994) 0.78
Helicobacter pylori-infection status and childhood living conditions are associated with signs of allergic diseases in an occupational population. Eur J Epidemiol (2008) 0.78
Effect of Helicobacter pylori and eradication therapy on gastrointestinal permeability. Implications for patients with seronegative spondyloarthritis. J Rheumatol (2005) 0.77
Anti-Saccharomyces cerevisiae (ASCA) and anti-endomysial antibodies in spondyloarthritis. Rheumatol Int (2011) 0.75
The promise and pitfalls of serologic testing in inflammatory bowel disease. Gastroenterol Clin North Am (2012) 0.75
A historical perspective of the spondyloarthritis. Curr Opin Rheumatol (2011) 0.75
2012 Brazilian Society of Rheumatology Consensus for the treatment of rheumatoid arthritis. Rev Bras Reumatol (2012) 1.05
Acute phase proteins for the diagnosis of bacterial infection and prediction of mortality in acute complications of cirrhosis. Ann Hepatol (2013) 0.98
A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis. Clin Rheumatol (2008) 0.90
Liver toxicity is rare in rheumatoid arthritis patients using combination therapy with leflunomide and methotrexate. Rev Bras Reumatol (2011) 0.84
Performance of RT-PCR in the detection of Streptococcus agalactiae in the anogenital tract of pregnant women. Arch Gynecol Obstet (2012) 0.84
Induced sputum versus bronchoalveolar lavage in the diagnosis of pneumocystis jiroveci pneumonia in human immunodeficiency virus-positive patients. Braz J Infect Dis (2007) 0.82
Disability and quality-of-life are not influenced by the prevalence of autoantibodies in early rheumatoid arthritis patients--results of the Brasília Cohort. Rev Bras Reumatol (2012) 0.81
Subclinical atherosclerosis in ankylosing spondylitis: is there a role for inflammation? Rev Bras Reumatol (2013) 0.81
External quality assurance with dried tube specimens (DTS) for point-of-care syphilis and HIV tests: experience in an indigenous populations screening programme in the Brazilian Amazon. Sex Transm Infect (2013) 0.80
Diagnosis of the pulmonary tuberculosis by polymerase chain reaction: a comparative study between HIV-positive and -negative individuals. Braz J Microbiol (2012) 0.80
Update on etiopathogenesis of systemic sclerosis. Rev Bras Reumatol (2014) 0.80
Drug survival and causes of discontinuation of the first anti-TNF in ankylosing spondylitis compared with rheumatoid arthritis: analysis from BIOBADABRASIL. Clin Rheumatol (2015) 0.80
Takayasu arteritis: anti-TNF therapy in a Brazilian setting. Rev Bras Reumatol (2010) 0.80
Intractable acquired autoimmune angioedema in a patient with systemic lupus erythematosus. Rev Bras Reumatol (2010) 0.78
Evaluation of multidrug resistance in 46 newly diagnosed patients with acute leukemia. Hematology (2012) 0.77
IGF-I and IGFBP-3 serum levels in patients hospitalized for complications of liver cirrhosis. Ann Hepatol (2013) 0.77
Musculoskeletal system assessment in an emergency room. Rev Bras Reumatol (2011) 0.77
Intrahospital spread of carbapenem-resistant Pseudomonas aeruginosa in a University Hospital in Florianópolis, Santa Catarina, Brazil. Rev Soc Bras Med Trop (2010) 0.77
Clinical and histological impact of previous hepatitis B virus infection in patients with chronic hepatitis C. Liver Int (2008) 0.76
Potential drug interactions in patients with rheumatoid arthritis. Rev Bras Reumatol (2011) 0.75
Mycophenolate mofetil in primary Sjögren's syndrome: a treatment option for agranulocytosis. Rev Bras Reumatol (2012) 0.75
Thoracic myelopathy due to calcification of the ligamentum flavum with hyperproteinorachia and responsive to steroid therapy: case report. Rev Bras Reumatol (2012) 0.75
Recommendations for the management and treatment of systemic sclerosis. Rev Bras Reumatol (2013) 0.75
Cholestasis as the initial presentation of relapsing polychondritis. Ann Hepatol (2011) 0.75
Paget's disease of bone: analysis of 134 cases from an island in Southern Brazil: another cluster of Paget's disease of bone in South America. Rheumatol Int (2010) 0.75
Quality of sputum in the performance of polymerase chain reaction for diagnosis of pulmonary tuberculosis. Braz J Infect Dis (2010) 0.75
Resolution of adalimumab-induced psoriasis after vitamin D deficiency treatment. Rheumatol Int (2011) 0.75
Comparison between two portable hemoglobinometers and a reference method to verify the reliability of screening in blood donors. Transfus Apher Sci (2013) 0.75
Lack of association between interleukin-18 polymorphisms and rheumatoid arthritis. Rev Bras Reumatol (2013) 0.75
2011 Consensus of the Brazilian Society of Rheumatology for diagnosis and early assessment of rheumatoid arthritis. Rev Bras Reumatol (2011) 0.75